Upregulation of transforming growth factor-β1 and vascular endothelial growth factor gene and protein expression in cyclosporin-induced overgrown edentulous gingiva in rats

Journal of Periodontology

Volumn 76, Issue 12, 2005, Pages 2267-2275

  Chen, Yen Teen ^a   Tu, Hsiao Pei ^a,b   Chin, Yu Tang ^a   Shen, E Chin ^c   Chiang, Cheng Yang ^a   Gau, Ching Hwa ^d   Fu, Earl ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAO YUAN GENERAL HOSPITAL   (Taiwan)

^d Kang Ning Junior College of Medical Care and Management   (Taiwan)

Author keywords

Adverse effects; Cyclosporine; Gingiva; Transforming growth factor beta1; Vascular endothelial growth factors

Indexed keywords

CYCLOSPORIN A; MESSENGER RNA; MINERAL OIL; PARAFORMALDEHYDE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ALVEOLAR RIDGE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DENTAL IMPRESSION; EDENTULOUSNESS; GENE EXPRESSION REGULATION; GINGIVA OVERGROWTH; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; RAT STRAIN; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; STAINING;

ANIMALS; CYCLOSPORINE; GINGIVA; GINGIVAL OVERGROWTH; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; MOUTH, EDENTULOUS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 30944433647     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.12.2267     Document Type: Article

References (64)

1. Rateitschak-Pluss EM, Hefti A, Lortscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
2. Deliliers GL, Santoro F, Polli N, Bruno E, Fumagalli L, Risciotti E. Light and electron microscopic study of cyclosporin A-induced gingival hyperplasia. J Periodontol 1986;57:771-775.
3. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
4. Schincaglia GP, Forniti F, Cavallini R, Piva R, Calura G, del Senno L. Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992;21: 181-185.
5. Zebrowski EJ, Pylypas SP, Odlum O, Johnson RB. Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporine. J Periodontol 1994;65:565-567.
6. Bartold PM. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A in vitro. J Periodontal Res 1989;24:314-321.
7. Tipton DA, Stricklin GP, Dabbous MK. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991;46:152-165.
8. Tipton DA, Pabst MJ, Dabbous MK. Interleukin-1 beta- and tumor necrosis factor-alpha-independent monocyte stimulation of fibroblast collagenase activity. J Cell Biochem 1990;44:253-264.
9. Petri JB, Schurk S, Gebauer S, Haustein UF. Cyclosporine A delays wound healing and apoptosis and suppresses activin beta-A expression in rats. Eur J Dermatol 1998;8:104-113.
10. Buduneli N, Kutukculer N, Aksu G, Atilla G. Evaluation of transforming growth factor-beta 1 level in crevicular fluid of cyclosporin A-treated patients. J Periodontol 2001;72:526-531.
11. Wright HJ, Chapple IL, Matthews JB. TGF-beta isoforms and TGF-beta receptors in drug-induced and hereditary gingival overgrowth. J Oral Pathol Med 2001; 30:281-289.
12. Cotrim P, de Andrade CR, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation. J Periodontol 2002; 73:1313-1322.
13. Cotrim P, Martelli-Junior H, Graner E, Sauk JJ, Coletta RD. Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta 1. J Periodontol 2003;74:1625-1633.
14. Wright HJ, Chapple IL, Blair F, Matthews JB. Crevicular fluid levels of TGFbeta1 in drug-induced gingival overgrowth. Arch Oral Biol 2004;49:421-425.
15. Iacopino AM, Doxey D, Cutler CW, et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: Possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997;68:73-83.
16. Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM. Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 1996;67:271-278.
17. Plemons JM, Dill RE, Rees TD, Dyer BJ, Ng MC, Iacopino AM. PDGF-B producing cells and PDGF-B gene expression in normal gingival and cyclosporine A-induced gingival overgrowth. J Periodontol 1996; 67:264-270.
18. Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
19. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-110.
20. Takahashi K, Lappin D, Kinane DF. In situ localization of cell synthesis and proliferation in periodontitis gingiva and tonsillar tissue. Oral Dis 1996;2:210-216.
21. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28:500-510.
22. Coletta RD, Almeida OP, Reynolds MA, Sauk JJ. Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-beta 1 autocrine stimulation. J Periodontal Res 1999;34:457-463.
23. Domeij H, Yucel-Lindberg T, Modeer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci 2002; 110:302-306.
24. Martelli-Junior H, Cotrim P, Graner E, Sauk JJ, Coletta RD. Effect of transforming growth factor-beta1, interleukin-6, and interferon-gamma on the expression of type I collagen, heat shock protein 47, matrix metalloproteinase (MMP)-1 and MMP-2 by fibroblasts from normal gingiva and hereditary gingival fibromatosis. J Periodontol 2003;74:296-306.
25. Fu E, Hsieh YD, Shen EC, Nieh S, Mao TK, Chiang CY. Cyclosporin-induced gingival overgrowth at the newly formed edentulous ridge in rats: A morphological and histometric evaluation. J Periodontol 2001;72:889-894.
26. Fu E, Nieh S, Wikesjö UM. The effect of plaque retention on cyclosporine-induced gingival overgrowth in rats. J Periodontol 1997;68:92-98.
27. Drissi H, Lomri A, Lasmoles F, Holy X, Zerath E, Marie PJ. Skeletal unloading induces biphasic changes in insulin-like growth factor-I mRNA levels and osteoblast activity. Exp Cell Res 1999;251:275-284.
28. Buch S, Han RN, Cabacungan J, et al. Changes in expression of platelet-derived growth factor and its receptors in the lungs of newborn rats exposed to air or 60% O(2). Pediatr Res 2000;48:423-433.
29. Koh JT, Kim OJ, Park YS, et al. Decreased expressions of thrombospondin 2 in cyclosporin A-induced gingival overgrowth. J Periodontal Res 2004;39:93-100.
30. Kulka M, Schwingshackl A, Befus AD. Mast cells express chloride channels of the CIC family. Inflamm Res 2002;51:451-456.
31. Gronert K, Kantarci A, Levy BD, et al. A molecular defect in intracellular lipid signaling in human neutrophils in localized aggressive periodontal tissue damage. J Immunol 2004;172:1856-1861.
32. Skaleric U, Kramar B, Petelin M, Pavlica Z, Wahl SM. Changes in TGF-beta 1 levels in gingiva, crevicular fluid and serum associated with periodontal inflammation in humans and dogs. Eur J Oral Sci 1997; 105:136-142.
33. Saito H, Tsujitani S, Oka S, et al. The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 1999;86:1455-1462.
34. Kusafuka K, Yamaguchi A, Kayano T, Takemura T. Immunohistochemical localization of members of the transforming growth factor (TGF)-beta superfamily in normal human salivary glands and pleomorphic adenomas. J Oral Pathol Med 2001;30:413-420.
35. Takata T, Miyauchi M, Ogawa I, et al. Immunoexpression of transforming growth factor beta in desmoplastic ameloblastoma. Virchows Arch 2000;436: 319-323.
36. van der Zee E, Everts V, Beertsen W. Cytokines modulate routes of collagen breakdown. Review with special emphasis on mechanisms of collagen degradation in the periodontium and the burst hypothesis of periodontal disease progression. J Clin Periodontol 1997;24:297-305.
37. Steinsvoll S, Halstensen TS, Schenck K. Extensive expression of TGF-beta1 in chronically-inflamed periodontal tissue. J Clin Periodontol 1999;26:366-373.
38. Tyler LW, Matossian K, Todd R, Gallagher GT, White RR, Wong DT. Eosinophil-derived transforming growth factors (TGF-alpha and TGF-beta 1) in human periradicular lesions. J Endod 1999;25:619-624.
39. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998;9:248-266.
40. Khanna A, Li B, Li P, Suthanthiran M. Regulation of transforming growth factor-beta 1 (TGF-beta 1) expression with a novel TGF-beta 1 complementary DNA. Biochem Biophys Res Commun 1994;204: 1061-1066.
41. Khanna A, Li B, Stenzel KH, Suthanthiran M. Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth. Transplantation 1994;57:577-582.
42. Li B, Sehajpal PK, Khanna A, et al. Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: Demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 1991;174:1259-1262.
43. James JA, Irwin CR, Linden GJ. Gingival fibroblast response to cyclosporin A and transforming growth factor beta 1. J Periodontal Res 1998;33:40-48.
44. Pilatti GL, Sampaio JE. The influence of chlorhexidine on the severity of cyclosporin A-induced gingival overgrowth. J Periodontol 1997;68:900-904.
45. Boltchi FE, Rees TD, Iacopino AM. Cyclosporine A-induced gingival overgrowth: A comprehensive review. Quintessence Int 1999;30:775-783.
46. Dill RE, Miller EK, Weil T, Lesley S, Farmer GR, Iacopino AM. Phenytoin increases gene expression for platelet-derived growth factor B chain in macrophages and monocytes. J Periodontol 1993;64:169-173.
47. Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004;65:2003-2017.
48. Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF. Nitric oxide modulates vascular endothelial growth factor and receptors in chronic cyclosporine nephrotoxicity. Kidney Int 2003;63:522-533.
49. Rezzani R, Rodella L, Dessy C, Daneau G, Bianchi R, Feron O. Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium. FEBS Lett 2003;552:125-129.
50. Bianchi R, Rodella L, Rezzani R. Cyclosporine A upregulates expression of matrix metalloproteinase 2 and vascular endothelial growth factor in rat heart. Int Immunopharmacol 2003;3:427-433.
51. Alvarez-Arroyo MV, Yague S, Wenger RM, et al. Cyclophilin-mediated pathways in the effect of cyclosporin A on endothelial cells: Role of vascular endothelial growth factor. Circ Res 2002;91:202-209.
52. Alvarez Arroyo MV, Suzuki Y, Yague S, et al. Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity. Transplantation 2002;74:1618-1624.
53. Kang DH, Kim YG, Andoh TF, et al. Post-cyclosporine-mediated hypertension and nephropathy: Amelioration by vascular endothelial growth factor. Am J Physiol Renal Physiol 2001;280:F727-F736.
54. Shihab FS, Bennett WM, Isaac J, Yi H, Andoh TF. Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity. Kidney Int 2002;62:422-433.
55. Naruishi K, Nishimura F, Yamada-Naruishi H, Omori K, Yamaguchi M, Takashiba S. C-jun N-terminal kinase (JNK) inhibitor, SP600125, blocks interleukin (IL)-6-induced vascular endothelial growth factor (VEGF) production: Cyclosporine A partially mimics this inhibitory effect. Transplantation 2003;76:1380-1382.
56. Hernandez GL, Volpert OV, Iniguez MA, et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: Roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 2001;193:607-620.
57. Cho ML, Cho CS, Min SY, et al. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Arthritis Rheum 2002; 46:1202-1209.
58. Rotwein P. Two insulin-like growth factor I messenger RNAs are expressed in human liver. Proc Natl Acad Sci USA 1986;83:77-81.
59. Rosenfeld RG. Insulin-like growth factors and the basis of growth. N Engl J Med 2003;349:2184-2186.
60. Ferraccioli G, Guerra P, Rizzi V, Bartoli E. Cyclosporin A increases somatomedin C insulin-like growth factor I levels in chronic rheumatic diseases. J Rheumatol 1995;22:1060-1064.
61. Soto L, Martin AI, Vara E, Lopez-Calderon A. Cyclosporin A treatment is able to revert the decrease in circulating GH and IGF-I and the increase in IGFBPs induced by adjuvant arthritis. Horm Metab Res 2001; 33:590-595.
62. Lopez-Calderon A, Soto L, Villanua MA, Vidarte L, Martin AI. The effect of cyclosporine administration on growth hormone release and serum concentrations of insulin-like growth factor-I in male rats. Life Sci 1999;64:1473-1483.
63. Johnson DW, Saunders HJ, Johnson FJ, Huq SO, Field MJ, Pollock CA. Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: Roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factor. J Pharmacol Exp Ther 1999;289:535-542.
64. Gooch JL, Tang Y, Ricono JM, Abboud HE. Insulin-like growth factor-I induces renal cell hypertrophy via a calcineurin-dependent mechanism. J Biol Chem 2001;276:42492-42500.